Nankai M, Klarica M, Fage D, Carter C
CNS Research Department, Synthelabo, Rueil Malmaison, France.
Neurochem Int. 1996 Nov;29(5):529-42. doi: 10.1016/0197-0186(96)00010-1.
NMDA increases the release of [14C]acetylcholine and [3H]spermidine or of [14C]GABA and [3H]dopamine from rat striatal slices. The pharmacology of these responses suggests that release of dopamine and GABA, acetylcholine, and spermidine is mediated, respectively, by three distinct NMDA receptor subtypes. IC50 values of compounds for the inhibition of dopamine and GABA release were closely matched, suggesting mediation by the same subtype. This receptor was generally more sensitive to all NMDA antagonists tested relative to that controlling acetylcholine or spermidine release (channel blockers, glycine antagonists, competitive antagonists and polyamine antagonists). The receptors controlling acetylcholine and spermidine release were characterised by lower antagonist sensitivity in general, and that controlling spermidine release was further defined by a marked insensitivity to ifenprodil, eliprodil, magnesium, dextromethorphan, dextrorphan, memantine, desipramine and polyamine spider toxins. In binding studies in which the displacement of 2 nM [3H]MK801 was studied in membranes prepared from a number of brain regions (in the presence of saturating concentrations of glutamate, glycine and spermidine) small regional differences in IC50 values were observed for a number of channel blockers, but no compound generated biphasic displacement curves that would allow masking of a particular subtype and it was not possible to detect binding components that were insensitive to memantine, dextrorphan dextromethorphan or desipramine. Ifenprodil produced biphasic displacement curves in the 1-day-old rat cortex and midbrain (with IC50 values of approximately 2 and 70 microM) and both ifenprodil and eliprodil displaced a small proportion (18%) of [3H]MK-801 with high affinity in the adult rat spinal cord. Displacement of [3H]MK801 by these compounds in all other adult brain regions (cortex, striatum, hippocampus, thalamus, pons, medulla, cerebellum) was monophasic and of low affinity. In general the subtype selectivity suggested by the release studies was not mirrored in the binding experiments, probably because of excessive heterogeneity of sites in the membrane preparations and to the subtype selectivity of [3H]MK801 itself.
N-甲基-D-天冬氨酸(NMDA)可增加大鼠纹状体切片中[14C]乙酰胆碱和[3H]亚精胺或[14C]γ-氨基丁酸(GABA)和[3H]多巴胺的释放。这些反应的药理学表明,多巴胺、GABA、乙酰胆碱和亚精胺的释放分别由三种不同的NMDA受体亚型介导。化合物对多巴胺和GABA释放抑制的半数抑制浓度(IC50)值紧密匹配,表明由同一亚型介导。相对于控制乙酰胆碱或亚精胺释放的受体(通道阻滞剂、甘氨酸拮抗剂、竞争性拮抗剂和多胺拮抗剂),该受体通常对所有测试过的NMDA拮抗剂更敏感。控制乙酰胆碱和亚精胺释放的受体通常表现出较低拮抗剂敏感性,而控制亚精胺释放的受体进一步表现为对ifenprodil、eliprodil、镁、右美沙芬、右啡烷、美金刚、地昔帕明和多胺蜘蛛毒素明显不敏感。在结合研究中(研究2 nM [3H]MK801在从多个脑区制备的膜中的置换情况,存在饱和浓度的谷氨酸、甘氨酸和亚精胺)观察到,多种通道阻滞剂的IC50值存在微小的区域差异,但没有化合物产生双相置换曲线从而可以掩盖特定亚型,并且无法检测到对美金刚、右啡烷、右美沙芬或地昔帕明不敏感(原文有误,应为敏感)的结合成分。I fenprodil在1日龄大鼠皮质和中脑产生双相置换曲线(IC50值约为2和70 microM),并且在成年大鼠脊髓中ifenprodil和eliprodil均以高亲和力置换一小部分(18%)的[3H]MK-801。这些化合物在所有其他成年脑区(皮质、纹状体、海马体、丘脑、脑桥、延髓、小脑)对[3H]MK801 的置换是单相的且亲和力低。总体而言,释放研究表明的亚型选择性在结合实验中未得到体现(反映),可能是因为膜制备中位点的过度异质性以及[3H]MK801本身的亚型选择性(原文有误,应为缺乏亚型选择性)。